G. BIAGI

424 total citations
61 papers, 361 citations indexed

About

G. BIAGI is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, G. BIAGI has authored 61 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Organic Chemistry, 18 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in G. BIAGI's work include Synthesis and Characterization of Heterocyclic Compounds (27 papers), Click Chemistry and Applications (25 papers) and Synthesis and Biological Evaluation (17 papers). G. BIAGI is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (27 papers), Click Chemistry and Applications (25 papers) and Synthesis and Biological Evaluation (17 papers). G. BIAGI collaborates with scholars based in Italy. G. BIAGI's co-authors include Oreste Livi, Irene Giorgi, Valerio Scartoni, Antonio Lucacchini, Claudia Martini, P. L. BARILI, Clementina Manera, Maria Enrica Ferretti, Laura Betti and Maria Letizia Trincavelli and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Veterinary Research Communications and Journal of Heterocyclic Chemistry.

In The Last Decade

G. BIAGI

59 papers receiving 342 citations

Peers

G. BIAGI

PHYSI

PHARM

Christian Glover United Kingdom

Prashantha Gunaga South Korea

Kin-ichi Imai Japan

Raghu Prasad Mailavaram India

Henry H. Gu United States

Sophie Huss France

Константин В. Саватеев Russia

Tomoharu Iino Japan

Mohsine Driowya France

Victor V. Fedotov Russia

Christian Glover United Kingdom

G. BIAGI

270 ×0.9

119 ×0.9

35 ×0.3

PHYSI

22 ×1.6

PHARM

7 ×0.5

Citations per year, relative to G. BIAGI G. BIAGI (= 1×) peers Christian Glover

Countries citing papers authored by G. BIAGI

Since Specialization

Citations

This map shows the geographic impact of G. BIAGI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. BIAGI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. BIAGI more than expected).

Fields of papers citing papers by G. BIAGI

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. BIAGI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. BIAGI. The network helps show where G. BIAGI may publish in the future.

Co-authorship network of co-authors of G. BIAGI

This figure shows the co-authorship network connecting the top 25 collaborators of G. BIAGI. A scholar is included among the top collaborators of G. BIAGI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. BIAGI. G. BIAGI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

BIAGI, G., et al.. (2004). Veterinary Case History: Forensic and Medical Legal Aspects. Veterinary Research Communications. 28(S1). 381–384. 1 indexed citations

BIAGI, G., Irene Giorgi, Clementina Manera, et al.. (1998). 1,2,3-トリアゾロ[1,5-a]キノキサリン類合成ならびにベンゾジアゼピンおよびアデノシン受容器への結合性. 33(2). 113–122. 30 indexed citations

BIAGI, G., et al.. (1998). A 3D model of the human A1 adenosine receptor. An evaluation of the binding free-energy with ligands.. PubMed. 15(3). 149–56. 7 indexed citations

BIAGI, G., Irene Giorgi, Oreste Livi, Valerio Scartoni, & Antonio Lucacchini. (1997). Synthesis of 4,6-disubstituted- and 4,5,6-trisubstituted-2-phenyl-pyrimidines and their affinity towards A1 adenosine receptors.. PubMed. 52(1). 61–5. 7 indexed citations

BIAGI, G., Irene Giorgi, Oreste Livi, et al.. (1997). ChemInform Abstract: Synthesis of New 1,2,3‐Triazolo(1,2‐a)benzotriazole Derivatives or Substituted 2,3‐Benzo‐1,3a,6,6a‐tetraazapentalenes. Part 2.. ChemInform. 28(45). 1 indexed citations

BIAGI, G., et al.. (1996). 1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations. Il Farmaco. 51(1). 13–18. 8 indexed citations

BIAGI, G., et al.. (1996). New 4‐(benzotriazol‐1‐yl)‐1,2,3‐triazole derivatives. Journal of Heterocyclic Chemistry. 33(6). 1847–1853. 10 indexed citations

BIAGI, G., Irene Giorgi, Oreste Livi, & Valerio Scartoni. (1995). Synthesis of new 3-benzyl-5-phenyl-7-alkylaminothiazolo [4,5-d]pyrimidine-2(3H)-thiones. Il Farmaco. 50(9). 579–586. 1 indexed citations

BIAGI, G., Irene Giorgi, Oreste Livi, et al.. (1994). N(6)-substituted 2-N-butyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. IV.. PubMed. 49(3). 183–6. 7 indexed citations

10.

BIAGI, G., et al.. (1994). N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives. V.. PubMed. 49(3). 187–91. 15 indexed citations

11.

BIAGI, G., et al.. (1994). 2-Aryl-8-azaadenosines: structure-activity relationships in the binding with A1 and A2 receptors. A comparison with the corresponding 9-benzyl-8-azaadenines. III.. PubMed. 49(2). 93–6. 7 indexed citations

12.

BIAGI, G., Irene Giorgi, Oreste Livi, et al.. (1993). Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives. Journal of Pharmaceutical Sciences. 82(9). 893–896. 25 indexed citations

13.

BIAGI, G., et al.. (1992). An 1,2,3-triazole derivative bioisoster of a potent in vitro prostaglandin synthesis inhibitor: preparation and biological activity.. PubMed. 47(1). 91–8. 2 indexed citations

14.

BIAGI, G., et al.. (1992). Structure-activity studies on a 1,2,3-triazole derivative, a potent in vitro inhibitor of prostaglandin synthesis: the role of the heterocyclic ring.. PubMed. 47(3). 335–44. 6 indexed citations

15.

BIAGI, G., et al.. (1991). ChemInform Abstract: Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C‐2 of the Nucleus of 8‐Azahypoxanthine.. ChemInform. 22(12). 2 indexed citations

16.

BIAGI, G., Oreste Livi, Valerio Scartoni, et al.. (1990). ChemInform Abstract: Superoxide Dismutase‐Like Activity of 1,2,3‐Triazole Derivatives.. ChemInform. 21(37). 49–57. 9 indexed citations

17.

Martini, Claudia, et al.. (1988). Specific Inhibition of Benzodiazepine Receptor Binding by Some 1,2,3-Triazole Derivatives. Journal of Pharmaceutical Sciences. 77(11). 977–980. 11 indexed citations

18.

BIAGI, G., Oreste Livi, & Antonio Lucacchini. (1985). 1-(4-SUBSTITUTED-BENZYL)-1,2,3-TRIAZOLES, INVITRO INHIBITORS OF PROSTAGLANDIN SYNTHESIS. 20(3). 267–271. 3 indexed citations

19.

SETTIMO, A. DA, et al.. (1984). ChemInform Abstract: 1,2,3‐Triazole Derivatives of Salicylic Acid.. Chemischer Informationsdienst. 15(20). 725–37. 1 indexed citations

20.

Livi, Oreste, et al.. (1983). Synthesis and in vitro antiinflammatory activity of 4-phenyl-1,2,3-triazole derivatives. 18(5). 471–475. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact